Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bile salt hydrolase (BSH; EC 3.5.1.24) is a bacterial enzyme widely expressed by the gut microbiota that catalyzes the deconjugation of glycine- or taurine-conjugated bile acids, representing the gateway reaction in microbial bile acid metabolism. By hydrolyzing the amide bond of conjugated bile acids, BSH generates unconjugated bile acids and free amino acids, which serve as substrates for downstream microbial modifications into secondary bile acids like deoxycholic acid (DCA) and lithocholic acid (LCA). This enzymatic activity significantly shapes the host bile acid pool, thereby modulating critical host signaling pathways mediated by bile acid receptors such as the farnesoid X receptor (FXR) and G protein-coupled bile acid receptor 1 (GPBAR1/TGR5). Dysregulation of BSH activity is strongly linked to metabolic and inflammatory disorders, including metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), obesity, and type 2 diabetes. Pharmacological targeting of BSH using gut-restricted, small-molecule covalent inhibitors (such as GR-7 and AAA-10) or natural compounds (such as caffeic acid phenethyl ester) represents a promising microbiome-targeted therapeutic strategy. By suppressing BSH activity, these inhibitors increase the levels of conjugated bile acids, reduce cytotoxic secondary bile acids, improve intestinal barrier integrity, and alleviate hepatic steatosis and inflammation.
Covalent or non-covalent inhibition of bacterial bile salt hydrolase (BSH) enzymes in the gut, preventing the deconjugation of primary bile acids and thereby reducing the formation of downstream cytotoxic secondary bile acids while preserving conjugated bile acids.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile salt hydrolase (BSH).